InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,792.04
(
0.71%
)
US TECH 100
19,721.72
(
0.76%
)
Dow Jones
42,512.00
(
1.03%
)
Brent Oil
77.06
(
0.56%
)
Bitcoin
60,786.03
(
0.34%
)
Post# of 253325
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 47
Posts 4718
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: rkrw post# 100481

Monday, 08/02/2010 7:36:50 PM

Monday, August 02, 2010 7:36:50 PM

Post# of 253325
mnta

If the manufacturing process is fixed, why should there be any greater inherent variation for Sanofi than Momenta?



because MNTA's manufacturing process had to result in product that fell within the parameters of that of SNY's (and i am sure they analyzed many batches to establish this range), so it follows that MNTA's manufacturing must result in product with variation no more than that of SNY's, but quite likely less than that of SNY's
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up